Article info

Download PDFPDF
‘Triple therapy’ (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis

Authors

  1. Correspondence to Dr May Khei Hu, Department of Respiratory Medicine, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK; maykhei.hu{at}nhs.net
View Full Text

Citation

Hu MK, Wood G, Dempsey O
‘Triple therapy’ (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis

Publication history

  • Received October 20, 2020
  • Revised November 25, 2020
  • Accepted November 29, 2020
  • First published December 11, 2020.
Online issue publication 
January 20, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.